An MHC anchor‐substituted analog of myelin oligodendrocyte glycoprotein 35–55 induces IFN‐γ and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Immunology

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200324502PMID 14768043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Both Activating and Inhibitory Fc Receptors Expressed on Mast Cells Regulate Experimental Allergic Encephalomyelitis Disease Severity 1

  2003cited by this paper
• Regulation of Polyclonal T Cell Responses by an MHC Anchor-Substituted Variant of Myelin Oligodendrocyte Glycoprotein 35-551

  2003cited by this paper
• Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis

  2003cited by this paper
• A controlled trial of natalizumab for relapsing multiple sclerosis.

  2003cited by this paper
• Dynamic Regulation of T Cell Immunity by CD431

  2002cited by this paper
• T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.

  2002cited by this paper
• A comparative analysis of B cell‐mediated myelin oligodendrocyte glycoprotein‐experimental autoimmune encephalomyelitis pathogenesis in B cell‐deficient mice reveals an effect on demyelination

  2002cited by this paper
• IgG Fc receptors.

  2001cited by this paper
• Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics

  2001cited by this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

  2000cited by this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.

  2000cited by this paper
• Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

  2000cited by this paper
• Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis

  2000cited by this paper
• Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

  2000cited by this paper
• Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests

  1999cited by this paper
• B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

  1999cited by this paper
• Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells

  1999cited by this paper
• Persistence of Peptide-induced CD4+ T cell Anergy In Vitro

  1998cited by this paper
• Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.

  1998cited by this paper
• Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease.

  1998cited by this paper
• Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis.

  1998cited by this paper
• Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

  1998cited by this paper
• Microvascular and Cellular Responses in the Optic Nerve of Rats with Acute Experimental Allergic Encephalomyelitis (EAE)

  1998cited by this paper
• Optic neuritis

  1998cited by this paper
• B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

  1998cited by this paper
• Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

  1997cited by this paper
• A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.

  1997cited by this paper
• P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues

  1997cited by this paper
• Models of T cell anergy: is there a common molecular mechanism?

  1996cited by this paper
• Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System

  1996cited by this paper
• Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology.

  1996cited by this paper
• Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).

  1996cited by this paper
• Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

  1996cited by this paper
• Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand.

  1995cited by this paper
• An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.

  1995cited by this paper
• A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells

  1995cited by this paper
• A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.

  1994cited by this paper
• Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.

  1993cited by this paper
• Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.

  1993cited by this paper
• Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis.

  1993cited by this paper
• Immunological aspects of demyelinating diseases.

  1992cited by this paper
• Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody.

  1992cited by this paper
• Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

  1991cited by this paper
• Demyelination Induced in Aggregating Brain Cell Cultures by a Monoclonal Antibody Against Myelin/Oligodendrocyte Glycoprotein

  1990cited by this paper
• Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

  1989cited by this paper
• Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.

  1980cited by this paper

• Taming the TCR: Antigen-Specific Immunotherapeutic Agents for Autoimmune Diseases

  2015influential citation
• The role of T cell receptor signal intensity in T helper 17 cell development

  2015cites this paper
• Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.

  2014cites this paper
• CNS Repair Requires Both Effector and Regulatory T Cells with Distinct Temporal and Spatial Profiles

  2014cites this paper
• MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration.

  2013cites this paper
• MicroRNA‐132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti‐inflammation: A new Ahr‐based exploration

  2013cites this paper
• Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.

  2011cites this paper
• Manipulating Antigenic Ligand Strength to Selectively Target Myelin-Reactive CD4+ T Cells in EAE

  2010cites this paper
• Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice

  2009cites this paper
• Loss of IFN-γ Enables the Expansion of Autoreactive CD4+ T Cells to Induce Experimental Autoimmune Encephalomyelitis by a Nonencephalitogenic Myelin Variant Antigen1

  2008cites this paper
• Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1

  2008cites this paper
• Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands

  2008cites this paper
• This information is current as Autoimmune Encephalomyelitis Cells in the Recovery from Experimental Regulatory T + CD 122 + Essential Role of CD 8

  2007cites this paper
• OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207

  2007cites this paper
• Modulation of MOG 37-50-specific CD8+ T cell activation and expansion by CD43.

  2006cites this paper
• Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury

  2006cites this paper
• Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG‐reactive T cells in H‐2b mice

  2006cites this paper
• Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.

  2006cites this paper
• Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice.

  2005cites this paper
• Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice.

  2005cites this paper
• Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.

  2005cites this paper
• MHC-bound antigens and proteomics for novel target discovery.

  2004cites this paper